Gluten sensitivity

Beyond Celiac Supports Bill That Would Require Products to Disclose Gluten-Containing Grains on Labels

Retrieved on: 
Wednesday, August 4, 2021

If passed, this bill would have a significant positive impact for those living with celiac disease and non-celiac gluten sensitivity as it requires all manufacturers to disclose any gluten-containing grains on their labels.

Key Points: 
  • If passed, this bill would have a significant positive impact for those living with celiac disease and non-celiac gluten sensitivity as it requires all manufacturers to disclose any gluten-containing grains on their labels.
  • Currently, wheat is the only gluten-containing grain that is required to be disclosed on food and beverage labels.
  • Beyond Celiac encourages everyone in the celiac disease and gluten-sensitive community to contact their representatives and senators to urge them to support FLMA.
  • Celiac disease is a serious genetic autoimmune disorder that affects an estimated 1 in 133 Americans, more than half of whom are still undiagnosed.

Beyond Celiac Partners with University of Sheffield, UK, to Research Neuropathology of Celiac Disease and Gluten-Related Disorders

Retrieved on: 
Tuesday, July 27, 2021

The $209,000 investment from Beyond Celiac will make it possible for scientists to expand investigation of the neurological and neuropsychological manifestations of celiac disease and gluten-related disorders.

Key Points: 
  • The $209,000 investment from Beyond Celiac will make it possible for scientists to expand investigation of the neurological and neuropsychological manifestations of celiac disease and gluten-related disorders.
  • This research will be a continuation of earlier work from Nigel Hoggard, MD, and Iain Croall, PhD, at Sheffield.
  • These talented researchers completed a study last year that provided the first compelling and objective scientific evidence that significant changes occur in the brain of celiac disease patients.
  • The new results will help to corroborate evidence and further clinical understanding of the neuropathology of celiac disease and gluten related disorders.

Global Celiac Disease Clinical Trial Pipeline Report 2021-2025: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Celiac Disease Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Celiac Disease Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Celiac Disease Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Celiac Disease market.
  • It covers emerging therapies for Celiac Disease in active clinical development stages including early and late stage clinical trials.
  • The report provides Celiac Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

IM Therapeutics Reports Positive Results in Safety, Tolerability and Mechanism of Action of Phase 1b Trial of Lead Drug IMT-002 in Type 1 Diabetes

Retrieved on: 
Wednesday, July 21, 2021

The single-blinded Phase 1b Multiple Ascending Dose (MAD) trial enrolled 30 T1D patients preselected for HLA-DQ8 between the ages of 18 and 45 into four groups.

Key Points: 
  • The single-blinded Phase 1b Multiple Ascending Dose (MAD) trial enrolled 30 T1D patients preselected for HLA-DQ8 between the ages of 18 and 45 into four groups.
  • Results of the Phase 1b study showed that IMT-002 was safe and well-tolerated.
  • IMT-002 completed a Phase 1a study in 2020 and has completed a Phase 1b study in T1D patients preselected for the HLA-DQ8 isoform.
  • The Company is building a broad HLA-targeted pipeline in autoimmune disorders including type 1 diabetes, celiac disease, and lupus.

The Very Good Butchers Announces New Gluten-Free Butcher's Select Line of Plant-Based Meats

Retrieved on: 
Tuesday, July 20, 2021

New Gluten-Free and Soy-Free Product Line to Compete with Beyond Meat and Impossible Foods

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - July 20, 2021) - The Very Good Food Company Inc. (TSXV: VERY) (OTCQB: VRYYF) (FSE: 0SI) ("VERY GOOD" or the "Company") today announced its forthcoming new gluten-free and soy-free Butcher's Select product line of plant-based meats available this summer.
  • The Butcher's Select line will not only appeal to households interested in a more plant-based diet but also extends the Company's consumer base to the estimated 30% of Americans who avoid gluten.
  • Butcher's Select is made with real, minimally processed ingredients, and is a 'cut above' other plant-based meats currently available.
  • "Butcher's Select will engage a new set of consumers with dietary restrictions or preferences and significantly increase our target customer base.

Dr. Alessio Fasano Joins Nemysis Ltd's Scientific Advisory Board

Retrieved on: 
Tuesday, July 20, 2021

Dr. Fasano is the author of several research papers and books on celiac disease and non-celiac gluten sensitivity.

Key Points: 
  • Dr. Fasano is the author of several research papers and books on celiac disease and non-celiac gluten sensitivity.
  • His vast and in-depth knowledge will be tremendously valuable as we move our pipeline of novel enzymatic therapy for gluten intolerance toward the clinical phases of development,"said Danilo Casadei Massari, Chairman and CEO of Nemysis Ltd.
    "It is a pleasure to have Alessio serve on Nemysis' scientific advisory board.
  • His deep expertise in celiac disease and gluten intolerance will be instrumental as we pursue therapeutic opportunities in these areas,"said Maria Cristina Comelli, Chief Scientific Officer of Nemysis.
  • "I welcome the opportunity to work with Nemysis' scientific leaders and SAB to bring new treatments to patients."

Beyond Celiac Publishes Research Connecting Brain Fog to Celiac Disease

Retrieved on: 
Thursday, July 1, 2021

Nearly 1,400 survey responses from those who have celiac disease and non-celiac gluten sensitivity were collected.

Key Points: 
  • Nearly 1,400 survey responses from those who have celiac disease and non-celiac gluten sensitivity were collected.
  • Brain fog starts most often between 30 minutes to 1 hour after ingesting gluten in both celiac disease (20.6%) and NCGS (23.0%) participant groups.
  • 26.7% of participants with celiac disease and 30.4% with NCGS reported their brain fog symptoms lasted 12 days, and 20.3% with celiac disease and 24.5% with NCGS reported symptoms lasting 35 days.
  • All of the latest research is clearly showing that celiac disease is not just a GI condition.

Beyond Celiac and National Minority Quality Forum to Co-Present at Prestigious DIA 2021 Life Sciences Event

Retrieved on: 
Thursday, June 24, 2021

Philadelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac ,the leading catalyst for a celiac disease cure in the United States, is honored to be presenting at the upcoming DIA 2021 Global Annual Meeting on June 28 alongside the National Minority Quality Forum (NMQF).

Key Points: 
  • Philadelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac ,the leading catalyst for a celiac disease cure in the United States, is honored to be presenting at the upcoming DIA 2021 Global Annual Meeting on June 28 alongside the National Minority Quality Forum (NMQF).
  • The panel will discuss systemic reasons for these challenges and quantitative data-mining approaches to solve them.
  • The problem of underdiagnosis is complex and embedded in health care systems and society, said Alesci.
  • This spring they co-hosted a virtual Town Hall discussion on diversity and disparity in celiac disease to further the conversation.

Canadian Celiac Association Resources Now Available in Arabic

Retrieved on: 
Wednesday, June 16, 2021

TORONTO, June 16, 2021 (GLOBE NEWSWIRE) -- As part of its ongoing effort to help Canadians suffering with celiac disease in the countrys diverse ethnic communities, the Canadian Celiac Association (CCA) today announced the release of Arabic language versions of its What is Celiac Disease and Living Gluten Free brochures [hotlink both to this url https://www.celiac.ca/landing-ar/ ).

Key Points: 
  • TORONTO, June 16, 2021 (GLOBE NEWSWIRE) -- As part of its ongoing effort to help Canadians suffering with celiac disease in the countrys diverse ethnic communities, the Canadian Celiac Association (CCA) today announced the release of Arabic language versions of its What is Celiac Disease and Living Gluten Free brochures [hotlink both to this url https://www.celiac.ca/landing-ar/ ).
  • Both resources provide the Canadian Arabic community with vital information about the disease, getting tested and dietary tips.
  • To learn more about celiac disease and the resources available from the CCA, visit https://www.celiac.ca/landing-ar/
    The Canadian Celiac Association / LAssociation canadienne de la maladie coeliaque, a volunteer-based federally registered charitable organization, empowers people who are adversely affected by gluten.
  • The association serves people with celiac disease, dermatitis herpetiformis and gluten disorders through its affiliated chapters across Canada.

Canadian Celiac Association Resources Now Available in Punjabi

Retrieved on: 
Wednesday, June 16, 2021

Both resources provide the Canadian Punjabi community with vital information about the disease, getting tested and dietary tips.

Key Points: 
  • Both resources provide the Canadian Punjabi community with vital information about the disease, getting tested and dietary tips.
  • To learn more about celiac disease and the resources available in other languages, visit https://www.celiac.ca/landing-pa/ .
  • The Canadian Celiac Association / LAssociation canadienne de la maladie coeliaque, a volunteer-based federally registered charitable organization, empowers people who are adversely affected by gluten.
  • The association serves people with celiac disease, dermatitis herpetiformis and gluten disorders through its affiliated chapters across Canada.